Streamline Other Operating Expenses vs Net Income From Continuing Ops Analysis
STRM Stock | USD 0.32 0.02 5.88% |
Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Other Operating Expenses and its Net Income From Continuing Ops accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Other Operating Expenses vs Net Income From Continuing Ops
Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Other Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.
The correlation between Streamline Health's Other Operating Expenses and Net Income From Continuing Ops is -0.76. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Other Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Streamline Health Solutions are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Other Operating Expenses i.e., Streamline Health's Other Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | -0.76 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Streamline Health. It is also known as Streamline Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income From Continuing Ops
Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Streamline Health's Selling General Administrative is very stable compared to the past year. As of the 27th of April 2024, Tax Provision is likely to grow to about 67.1 K, while Issuance Of Capital Stock is likely to drop about 9.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 17.4M | 24.9M | 28.6M | 18.9M | Depreciation And Amortization | 5.1M | 4.5M | 5.2M | 2.8M |
Streamline Health fundamental ratios Correlations
Click cells to compare fundamentals
Streamline Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Streamline Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 70.7M | 74.3M | |
Short Long Term Debt Total | 3.8M | 2.7M | 10.1M | 9.7M | 11.2M | 5.8M | |
Other Current Liab | 2.5M | 1.5M | 6.5M | 7.0M | 8.1M | 8.5M | |
Total Current Liabilities | 15.6M | 7.4M | 13.5M | 16.8M | 19.3M | 10.0M | |
Total Stockholder Equity | 16.0M | 17.5M | 34.0M | 35.5M | 40.8M | 42.9M | |
Property Plant And Equipment Net | 152K | 495K | 341K | 111K | 99.9K | 94.9K | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 3.6M | 3.8M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (87.3M) | (83.0M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 719.9K | 1.1M | |
Non Current Assets Total | 25.1M | 18.7M | 46.7M | 45.5M | 52.4M | 55.0M | |
Non Currrent Assets Other | 695K | 886K | 948K | 1.7M | 1.5M | 1.2M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 10.0M | 5.1M | |
Common Stock Shares Outstanding | 22.7M | 30.2M | 42.8M | 49.3M | 56.7M | 59.6M | |
Liabilities And Stockholders Equity | 31.7M | 26.0M | 61.8M | 61.5M | 70.7M | 74.3M | |
Non Current Liabilities Total | 55K | 1.1M | 14.3M | 9.2M | 10.6M | 6.7M | |
Other Current Assets | 919K | 416K | 568K | 710K | 639K | 1.2M | |
Other Stockholder Equity | 95.1M | 96.3M | 119.2M | 132.0M | 151.8M | 159.4M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 29.9M | 16.3M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 18.4M | 12.8M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 902.8K | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 7.6M | 5.7M | |
Cash And Short Term Investments | 1.6M | 2.4M | 9.9M | 6.6M | 7.6M | 5.7M | |
Property Plant And Equipment Gross | 152K | 495K | 341K | 357K | 321.3K | 305.2K | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock Total Equity | 208K | 305K | 316K | 576K | 662.4K | 695.5K | |
Common Stock | 305K | 316K | 478K | 576K | 662.4K | 695.5K | |
Property Plant Equipment | 152K | 104K | 341K | 5.9M | 6.8M | 7.2M | |
Current Deferred Revenue | 8.0M | 3.9M | 5.8M | 8.4M | 9.6M | 6.8M | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 23.7M | 12.7M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Retained Earnings Total Equity | (76.6M) | (79.4M) | (79.1M) | (97.0M) | (87.3M) | (91.7M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M | |
Deferred Long Term Liab | 55K | 130K | 806K | 167K | 150.3K | 142.8K |
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.